NCT04638140 is a clinical trial in Hip Arthrosis, sponsored by Universitaire Ziekenhuizen KU Leuven.

Who is sponsoring NCT04638140?

NCT04638140 is sponsored by Universitaire Ziekenhuizen KU Leuven.

What condition does NCT04638140 study?

NCT04638140 studies Hip Arthrosis, Hip Injuries.

Is NCT04638140 still recruiting?

NCT04638140 is currently terminated. Last updated 3 July 2024.

Last reviewed 2024-07-03 · How we verify

NCT04638140

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Retrospective Assessment of the Morphology of Acetabular Defects: A 3D Reconstruction Approach

Terminated Last updated 3 July 2024

What this trial tests

trial in Hip Arthrosis in 200 participants. Terminated before completion.

Timeline

31 August 2018

Primary endpoint
11 May 2023

11 May 2023

Quick facts

Lead sponsor	Universitaire Ziekenhuizen KU Leuven
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	200
Start date	31 August 2018
Primary completion	11 May 2023
Estimated completion	11 May 2023
Sites	1 location across Belgium

Conditions studied

Hip Arthrosis — all drugs for Hip Arthrosis →
Hip Injuries — all drugs for Hip Injuries →

Sponsor

Universitaire Ziekenhuizen KU Leuven — full company profile →

Who can join

Eligibility, any sex, with Hip Arthrosis or Hip Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, we aim to develop a statistical shape model and use it to reconstruct the shape of acetabula with severe defects (Paprosky 3a-3b). This will allow us to visualise and assess the morphology of the missing bone. In future studies we will use the obtained results to improve the design of acetabular implants for revision surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Universitaire Ziekenhuizen KU Leuven trials

Trials by the same sponsor.

NCT06831955 — LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer · Phase 2 · recruiting
NCT07356505 — Efficacy and Safety of Micra AV2 Transcatheter Pacing System · NA · recruiting
NCT07286968 — Gastro-Intestinal Digestion and Physiology After Bariatric Surgery · recruiting
NCT06962137 — Phase II RAINSPOT: Zolbetuximab-Paclitaxel-Ramucirumab for CLDN18.2 Positive Gastro-esophageal Cancer · Phase 2 · recruiting
NCT07270536 — Accelerated Pacing and Cardiac Filling Pressures During Exercise in Patients With Heart Failure With Preserved Ejection · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04638140 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universitaire Ziekenhuizen KU Leuven
Last refreshed: 3 July 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04638140.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing